JGGDR
JGP Global Gestao de Recursos Portfolio holdings
AUM
$204M
This Quarter Return
+13.1%
1 Year Return
+109.69%
3 Year Return
+285.93%
5 Year Return
+345.7%
10 Year Return
+378.07%
AUM
$26.6M
AUM Growth
+$26.6M
(-85%)
Cap. Flow
-$158M
Cap. Flow
% of AUM
-594.5%
Top 10 Holdings %
Top 10 Hldgs %
47.03%
Holding
70
New
9
Increased
9
Reduced
27
Closed
25
Top Buys
| 1 |
Microsoft
MSFT
|
$1.87M |
| 2 |
Apple
AAPL
|
$796K |
| 3 |
Sunrun
RUN
|
$288K |
| 4 |
Teleflex
TFX
|
$233K |
| 5 |
Molina Healthcare
MOH
|
$230K |
Top Sells
| 1 |
Mercado Libre
MELI
|
$39.9M |
| 2 |
iShares MSCI Brazil ETF
EWZ
|
$37.2M |
| 3 |
Vale
VALE
|
$18.8M |
| 4 |
ARCE
Arco Platform Limited Class A Common Shares
ARCE
|
$16.4M |
| 5 |
CZZ
Cosan Limited
CZZ
|
$11.7M |
Sector Composition
| 1 | Healthcare | 84.97% |
| 2 | Technology | 11.11% |
| 3 | Consumer Staples | 0% |
| 4 | Communication Services | 0% |
| 5 | Materials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Humana
HUM
$36.5B
| $424K | 1.59% |
1,034
+38
| +4% | +$15.6K |
|
27
Merck
MRK
$210B
| $405K | 1.52% |
4,953
+777
| +19% | +$63.5K |
|
28
DexCom
DXCM
$29.5B
| $400K | 1.5% |
1,082
-56
| -5% | -$20.7K |
|
29
Elevance Health
ELV
$71.8B
| $396K | 1.49% |
1,234
-28
| -2% | -$8.99K |
|
30
Hologic
HOLX
$14.9B
| $386K | 1.45% |
5,299
-56
| -1% | -$4.08K |
|
31
Bristol-Myers Squibb
BMY
$96B
| $374K | 1.41% |
6,028
-410
| -6% | -$25.4K |
|
32
AstraZeneca
AZN
$248B
| $364K | 1.37% |
7,277
+222
| +3% | +$11.1K |
|
33
Eli Lilly
LLY
$657B
| $345K | 1.3% |
2,046
+221
| +12% | +$37.3K |
|
34
West Pharmaceutical
WST
$17.8B
| $309K | 1.16% |
1,092
-28
| -3% | -$7.92K |
|
|
35
Sunrun
RUN
$3.68B
| $288K | 1.08% |
+4,150
| New | +$288K |
|
36
Neurocrine Biosciences
NBIX
$13.8B
| $272K | 1.02% |
2,841
-71
| -2% | -$6.8K |
|
37
QuidelOrtho
QDEL
$1.95B
| $263K | 0.99% |
1,463
-68
| -4% | -$12.2K |
|
38
Sarepta Therapeutics
SRPT
$1.78B
| $262K | 0.99% |
1,538
-106
| -6% | -$18.1K |
|
|
39
Teleflex
TFX
$5.59B
| $233K | 0.88% |
+566
| New | +$233K |
|
|
40
Molina Healthcare
MOH
$9.8B
| $230K | 0.86% |
+1,083
| New | +$230K |
|
|
SAGE
41
DELISTED
Sage Therapeutics
SAGE
| $226K | 0.85% |
+2,618
| New | +$226K |
|
42
Ultragenyx Pharmaceutical
RARE
$2.89B
| $220K | 0.83% |
+1,586
| New | +$220K |
|
|
XLRN
43
DELISTED
Acceleron Pharma Inc.
XLRN
| $220K | 0.83% |
+1,718
| New | +$220K |
|
44
Iovance Biotherapeutics
IOVA
$807M
| $211K | 0.79% |
+4,544
| New | +$211K |
|
45
Cooper Companies
COO
$13.4B
| $207K | 0.78% |
571
-29
| -5% | -$10.5K |
|
|
46
Mercado Libre
MELI
$125B
| – | – |
-36,836
| Closed | -$39.9M |
|
47
Pfizer
PFE
$141B
| – | – |
-5,639
| Closed | -$207K |
|
48
PayPal
PYPL
$67.1B
| – | – |
-1,500
| Closed | -$296K |
|
49
Acadia Pharmaceuticals
ACAD
$4.38B
| – | – |
-22,916
| Closed | -$945K |
|
50
Alnylam Pharmaceuticals
ALNY
$58.5B
| – | – |
-1,426
| Closed | -$208K |
|